Michel Lagarde
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2023-10-05
- Valid until
- still holds
- Published
- 2023-10-05
- Recorded by AsOf
- 2026-11-12
- Checked
- 2026-11-12 · its source page states the value and the date
- Confidence
- 0.95
Sources
“On October 3, 2023, Michel Lagarde was appointed as a new member of the board of directors (the “Board”) of Vertex Pharmaceuticals Incorporated (the “Company”), effective on October 5, 2023.”— what the page says, read 2026-11-12
Cite this claim
Plain text
AsOf. "Vertex Pharmaceuticals board member: Michel Lagarde", as of 2023-10-05. Claim clm_CE6447C7794C, https://asof.is/claim/clm_CE6447C7794C, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/0000875320-23-000023-index.htm.
APA
AsOf. (2023). Vertex Pharmaceuticals board member: Michel Lagarde (as of 2023-10-05) [Record clm_CE6447C7794C]. Retrieved November 13, 2026, from https://asof.is/claim/clm_CE6447C7794C (source: https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/0000875320-23-000023-index.htm)
BibTeX
@misc{asof_clm_CE6447C7794C,
author = {AsOf},
title = {Vertex Pharmaceuticals board member: Michel Lagarde},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_CE6447C7794C}},
note = {Claim clm\_CE6447C7794C, as of 2023-10-05; source: https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/0000875320-23-000023-index.htm},
urldate = {2026-11-13}
}On the record
/claim/clm_CE6447C7794C.md/v1/claims/clm_CE6447C7794Csubmit a correction